Dalazatide (ShK-186) is a specific Kv1.3 potassium channel peptide inhibitor. Dalazatide can be used in the study of autoimmune diseases such as multiple sclerosis (MS), lupus erythematosus, psoriasis, rheumatoid arthritis, type 1 diabetes and inflammatory bowel disease[1][2][3].
Molecular Weight:
4442.10
Purity:
99.23
CAS Number:
[1081110-69-1]
Formula:
C184H296N57O55PS7
Target:
Potassium Channel
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted